Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
J Neuroimmunol. 2021 Dec 15;361:577755. doi: 10.1016/j.jneuroim.2021.577755. Epub 2021 Oct 20.
Vaccine administration may be involved in the development of some central nervous system demyelinating diseases. The COVID-19 vaccine is being administered to the entire population, but to date, little association between vaccination and the risk of developing multiple sclerosis (MS) has been suggested, and only a few case reports have been published. Here, we present a 40-year-old woman who developed cervical myelitis after receiving the COVID-19 vaccine. Myelitis was considered the initial clinical manifestation of MS. Our case suggests a possible link between the vaccination and the clinical MS attack.
疫苗接种可能与一些中枢神经系统脱髓鞘疾病的发生有关。目前正在为全体人群接种 COVID-19 疫苗，但迄今为止，接种疫苗与多发性硬化症（MS）风险之间的关联很少被提出，并且仅发表了少数病例报告。在这里，我们介绍了一位 40 岁女性，她在接种 COVID-19 疫苗后发生了颈髓炎。 髓炎被认为是 MS 的初始临床表现。我们的病例提示接种疫苗与临床 MS 发作之间可能存在联系。
